BigHat Biosciences

About:

BigHat Biosciences is a protein therapeutics company that develops an antibody design platform guided by artificial intelligence.

Website: http://www.bighatbio.com

Twitter/X:

Top Investors: Bristol-Myers Squibb, Andreessen Horowitz, 8VC, Section 32, AME Cloud Ventures

Description:

BigHat is a developer of an AI-guided protein therapeutic platform used to integrate antibody characterization lab with machine learning technologies to engineer molecules with more complex functions and better biophysical properties. The company is applying these design capabilities to develop new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases.